Novonesis (novozymes)-ADRNVZMY
13F holders, Q2 2025 (June 30)11holders +3
3new positions
0sold out
$71.53avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Novonesis (novozymes)-ADR (NVZMY) in their 13F filings, up 3 from Q1 2025. 3 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($753K), Sterling Capital Management LLC ($467K) and S&co Inc. ($321K).
- Company
- Novonesis (novozymes)-ADR
- Filed as
- NOVOZYMES A/S-UNSPONS ADR (Q2 2025)
- CUSIP
- 670108109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $237K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 3,977 shares bought and 412 shares sold, net +3,565 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Rhumbline Advisers | 0.00% | Add +0.2% | 10,505 | $753K |
| Sterling Capital Management LLC | 0.01% | Reduce -4.3% | 6,542 | $467K |
| S&co Inc. | 0.02% | No change | 4,500 | $321K |
| Boston Common Asset Management, LLC | 0.01% | New | 3,060 | $219K |
| GAMMA Investing LLC | 0.01% | Add +36.5% | 2,364 | $169K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -6.4% | 1,626 | $116K |
| Mar Vista Investment Partners LLC | 0.00% | No change | 702 | $50K |
| First Horizon Advisors, Inc. | 0.00% | New | 249 | $18K |
| Brooklyn Investment Group | 0.00% | Add +19.1% | 81 | $6K |
| Copeland Capital Management, LLC | 0.00% | Reduce -14.0% | 49 | $4K |
| Salomon & Ludwin, LLC | 0.00% | New | 5 | $358 |
"% of holder's portfolio" is NVZMY's weight in each manager's 13F, not the share of Novonesis (novozymes)-ADR the manager owns.